[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1135 Introduced in House (IH)]

<DOC>






115th CONGRESS
  2d Session
H. RES. 1135

  Raising awareness of the lifesaving role of three-dimensional (3D) 
 digital breast tomosynthesis screening in detection and treatment of 
                             breast cancer.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            October 26, 2018

 Mr. Paulsen submitted the following resolution; which was referred to 
                  the Committee on Energy and Commerce

_______________________________________________________________________

                               RESOLUTION


 
  Raising awareness of the lifesaving role of three-dimensional (3D) 
 digital breast tomosynthesis screening in detection and treatment of 
                             breast cancer.

Whereas, in 2012, the Food and Drug Administration approved three-dimensional 
        (3D) digital tomosynthesis, a modification of digital mammography that 
        uses a moving x-ray source and a digital detector that allows for the 
        reconstruction of a three-dimensional dataset;
Whereas 3D digital tomosynthesis dramatically improves the imaging of breast 
        lesions and breast cancer by eliminating overlap from surrounding 
        tissues and structures;
Whereas peer-reviewed research published in the Journal of the American Medical 
        Association in 2014 has documented that tomosynthesis used with digital 
        mammography is associated with up to a 41-percent increase in the 
        detection of invasive cancers and up to a 37-percent drop in patient 
        recalls to have additional breast imaging workup, such as a diagnostic 
        mammogram or a breast ultrasound, due to ambiguous results;
Whereas earlier detection of breast cancers is positively correlated to improved 
        patient survival and outcomes and reduced cost of treatment;
Whereas peer-reviewed research has concluded that broader adoption of this 
        technology presents an opportunity to deliver value-based care to the 
        Medicaid population and to address disparities and barriers to access to 
        preventive care for some of the Nation's most vulnerable citizens;
Whereas while the adoption of 3D tomosynthesis has been growing, 52 percent of 
        United States mammography facilities are still without this lifesaving 
        technology;
Whereas Medicare covers 3D tomosynthesis and it is estimated that at least 86 
        percent of covered lives in the private insurance market are covered for 
        this technology; and
Whereas the utilization and coverage of 3D tomosynthesis can save lives, improve 
        treatment regimens, and reduce health care costs: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) acknowledges the immense value of three-dimensional 
        (3D) digital breast tomosynthesis;
            (2) encourages all Federal health care programs to promote 
        access and coverage of this lifesaving technology;
            (3) calls upon all private sector insurers to cover and 
        fairly reimburse for this technology; and
            (4) supports efforts by the public health community to 
        publicize the merits and availability of 3D digital breast 
        tomosynthesis.
                                 <all>